RELATED PARTY TRANSACTIONS (Details) |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Apr. 30, 2024
USD ($)
director
shares
|
Dec. 31, 2024
USD ($)
shares
|
Dec. 31, 2023
USD ($)
shares
|
|
| Related Party Transaction [Line Items] | |||
| Due to related party | $ 531,000 | $ 556,000 | |
| Related party transaction, number of board members | director | 1 | ||
| Related party transaction, monthly amount of transaction | $ 5,000 | ||
| Options granted (in shares) | shares | 1,505,000 | 4,363,800 | |
| General and administrative | $ 8,836,000 | $ 8,516,000 | |
| Total stock based compensation | 4,298,736 | 3,208,076 | |
| Related Party | |||
| Related Party Transaction [Line Items] | |||
| Due to related party | 5,000 | 2,000 | |
| Consulting and professional fees | $ 20,000 | ||
| Options granted (in shares) | shares | 70,000 | ||
| General and administrative | 75,800 | ||
| Total stock based compensation | $ 30,800 | ||
| Related Party | Stock options | |||
| Related Party Transaction [Line Items] | |||
| Vesting period | 36 months | ||
| X | ||||||||||
- Definition Related Party Transaction, Monthly Amount Of Transaction No definition available.
|
| X | ||||||||||
- Definition Related Party Transaction, Number Of Board Members No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|